Entourage Phytolab
Entourage Phytolab is a São Paulo-based pharmaceutical company founded in 2015 that develops and sells ANVISA-approved medical cannabis products, most notably the QuickStrip™ oral dissolvable thin film, targeting Brazil's 672,000+ registered medical cannabis patients through pharmaceutical distribution and digital medical access portals.
- Company typePrivate
- Founded2015
- HeadquartersSão Paulo, Brazil
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What Entourage Phytolab does
Entourage Phytolab is a Brazilian pharmaceutical company founded in 2015 and headquartered in São Paulo that develops and commercializes medical cannabis formulations under a proprietary technology platform called Tecnologia Fusionner (Fusionner Technology). The company's stated mission is to apply the same pharmaceutical rigor to medical cannabis that conventional therapies receive, and its core product is QuickStrip™, an oral dissolvable thin film delivering cannabinoids via sublingual and buccal administration routes, developed in partnership with Canadian biotechnology firm Rapid Dose Therapeutics Corp. and launched commercially in Brazil in February 2026 following ANVISA regulatory approval of sublingual and buccal formats earlier that year.
The company targets Brazil's registered medical cannabis patient base, which exceeded 672,000 users as of early 2026, serving them through a network that includes a medical access portal (acesso/medico) for healthcare professionals, a patient access portal (acesso/paciente), and a representative hub with dosing calculators, COA (Certificate of Analysis) repository, catalogs, and a digital library. Distribution occurs through Brazilian pharmaceutical channels in partnership with Rapid Dose Therapeutics, which provides the QuickStrip technology, and Nexxions, which serves as the U.S. distribution partner. The company is private, employs 11-50 people, and has no disclosed revenue, funding history, or public ownership structure.
Entourage Phytolab operates in a Brazilian medical cannabis market valued at $856.53 million in 2025 and projected to reach $1,546.74 million by 2034, with its commercial model effectively a B2B2C structure that flows product through pharmaceutical distribution to prescribers and patients. The company is differentiated by being one of the first oral dissolvable strip medical cannabis formulations in Brazil, by its Fusionner Technology platform, and by a regulatory first-mover position in the newly opened sublingual/buccal category. Pricing is quote-based and not publicly disclosed.
Entourage Phytolab firmographics
Firmographics- Name
- Entourage Phytolab
- Legal name
- Entourage Phytolab
- Website
- https://entouragelab.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Entourage Phytolab is a São Paulo-based pharmaceutical company founded in 2015 that develops and sells ANVISA-approved medical cannabis products, most notably the QuickStrip™ oral dissolvable thin film, targeting Brazil's 672,000+ registered medical cannabis patients through pharmaceutical distribution and digital medical access portals.
- Ownership category
- akta.pro rank
Entourage Phytolab industry classification
Industry- Product category
- Medical Cannabis Pharmaceuticals
- NAICS
- Pharmacies and Drug Retailers (45611)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)
- akta.pro secondary industry
- Medical Cannabis Dispensaries (CRANAFAB)
Keywords
Where Entourage Phytolab is headquartered
LocationHeadquarters
- HQ city
- São Paulo
- HQ country
- Brazil
- HQ region
- Latin America
Markets served
Entourage Phytolab business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales
Revenue model
- Medical Cannabis Pharmaceutical Products: Revenue generated through sale of approved medical cannabis formulations, including oral thin film strips (QuickStrip), distributed through pharmaceutical channels in Brazil following ANVISA regulatory approval.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Entourage Phytolab product offering
Product offeringCore offering
Entourage Phytolab is a Brazilian pharmaceutical company that manufactures and distributes medical cannabis products, with its flagship offering being QuickStrip™, an oral dissolvable thin film for sublingual and buccal administration. The company develops these formulations using its proprietary Fusionner Technology platform, operating in Brazil's ANVISA-regulated medical cannabis market following regulatory approval expanding permissible routes of administration in January 2026.
Product overview
Entourage Phytolab is a Brazilian pharmaceutical company specializing in medical cannabis products. The company operates a proprietary technology platform called Tecnologia Fusionner and commercializes QuickStrip™ medical cannabis oral thin film products for sublingual and buccal administration through a strategic partnership with Canadian biotech company Rapid Dose Therapeutics. The company targets Brazil's registered cannabis patient population through healthcare provider and patient access channels, with regulatory approval from ANVISA.
Differentiator
Problem solved
Functional benefit
Products and services
- QuickStrip™ Medical Cannabis Oral Thin Film Medical cannabis oral thin film for sublingual and buccal administration, one of the first oral dissolvable strip medical cannabis formulations to enter Brazil's healthcare market, commercialized following ANVISA approval for medical treatment.
Companies that use Entourage Phytolab
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
Entourage Phytolab technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Entourage Phytolab partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Rapid Dose Therapeutics Corp.coreStrategic partnership for commercial launch of QuickStrip medical cannabis oral thin film in Brazil following ANVISA regulatory approval. Rapid Dose Therapeutics, a Canadian biotechnology company, provides the proprietary oral dissolvable strip technology while Entourage Phytolab serves as the Brazilian pharmaceutical partner for local market access and distribution.
- NexxionscoreU.S. distribution partner for QuickStrip medical cannabis products, collaborating with Rapid Dose Therapeutics and Entourage Phytolab for the Brazil market launch following ANVISA approval.
Scale indicators2 records
Recent moves4 records
Expansion highlights4 records
Entourage Phytolab competitors and assessment
Company assessmentDirect peers
- Rapid Dose Therapeutics Corp. Canadian biotech that owns the proprietary QuickStrip™ oral dissolvable thin film technology commercialized with Entourage in Brazil. Direct technology partner and co-launcher; highly relevant given their intertwined product and distribution relationship.
Broad incumbents
- Canopy Growth Corporation: Major global cannabis producer with a portfolio of medical cannabis formulations including oils, capsules, and softgels. Comparable as a multinational pharmaceutical-grade cannabis player targeting registered patient populations.
- Aurora Cannabis Inc. Canadian-licensed producer of medical cannabis products sold through pharmacies and healthcare channels. Comparable in business model — pharmaceutical-grade medical cannabis distribution through regulated healthcare channels.
- Jazz Pharmaceuticals (GW Pharmaceuticals): Owner of cannabinoid-based prescription medicines (Sativex, Epidiolex). Comparable as a pharmaceutical-grade cannabis therapeutics company operating in regulated prescription drug channels globally.
- Medical Marijuana Inc. U.S.-headquartered medical cannabis and hemp-CBD company with international distribution including Latin America. Comparable in targeting medical cannabis patient populations with pharmaceutical-style branding.
- Cronos Group: Global cannabis company with medical cannabis offerings across multiple formats and geographies. Comparable as a multi-product, multi-geography medical cannabis player with pharmaceutical partnerships.
- Tilray Brands: Global medical and adult-use cannabis producer with established pharmaceutical distribution and medical cannabis offerings across multiple geographies, including Latin America. Comparable as a large-scale, multi-format medical cannabis company competing for similar prescriber and patient relationships.
Regional players
- VerdeMed (Verde Cannabis): Brazil-focused medical cannabis company operating in the same domestic regulatory framework (ANVISA) as Entourage. Direct regional peer competing for the same Brazilian registered patient population.
- Prati-Donaduzzi: Major Brazilian generic pharmaceutical manufacturer that has expanded into cannabis-based products. Comparable as a Brazilian pharmaceutical-grade cannabis manufacturer targeting the same ANVISA-regulated distribution channels.
- EaseLabs Pharma: Brazilian pharmaceutical company focused on cannabis-derived medicines, operating under ANVISA regulation. Direct regional peer with overlapping medical cannabis product positioning in Brazil.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Entourage Phytolab financial estimates
Financial estimateRevenue estimate
Valuation estimate
Entourage Phytolab leadership team
Management profileNumber of profiles
Entourage Phytolab funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Entourage Phytolab M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Entourage Phytolab
What does Entourage Phytolab do?
Entourage Phytolab is a Brazilian pharmaceutical company that manufactures and distributes medical cannabis products, with its flagship offering being QuickStrip™, an oral dissolvable thin film for sublingual and buccal administration. The company develops these formulations using its proprietary Fusionner Technology platform, operating in Brazil's ANVISA-regulated medical cannabis market following regulatory approval expanding permissible routes of administration in January 2026.
Is Entourage Phytolab a public or private company?
Entourage Phytolab is a private company. It is classified as unknown and is currently operating.
When was Entourage Phytolab founded?
Entourage Phytolab was founded in 2015. It employs 11 to 50 people.
Where is Entourage Phytolab based?
Entourage Phytolab is headquartered in São Paulo, Brazil, in the Latin America region.
How does Entourage Phytolab make money?
One revenue line is on record: medical Cannabis Pharmaceutical Products.
Who are Entourage Phytolab's main competitors?
Rapid Dose Therapeutics Corp. is listed as a direct peer. Broad incumbents are Canopy Growth Corporation, Aurora Cannabis Inc., Jazz Pharmaceuticals (GW Pharmaceuticals), Medical Marijuana Inc., Cronos Group and Tilray Brands. Regional players are VerdeMed (Verde Cannabis), Prati-Donaduzzi and EaseLabs Pharma.
Does Entourage Phytolab have an API?
No public API is recorded for Entourage Phytolab.
What industry is Entourage Phytolab in?
Entourage Phytolab's product category is Medical Cannabis Pharmaceuticals. Its primary akta.pro industry code is CRANAFAI, Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services), with a secondary code of CRANAFAB, Medical Cannabis Dispensaries. Its NAICS code is 45611 and its SIC code is 2834.